How APoB levels may change the way we predict CHD
Study suggests measuring the levels may be superior to testing for cholesterol
Levels of apolipoprotein B (APoB) may be a better predictor of coronary heart disease risk than either low-density lipoprotein cholesterol (LDL-C) or triglyceride levels, an international study suggests.
The research also helps clarify the long-debated role of triglycerides in atherosclerosis.
Commentators suggest that the UK study findings – Âdrawing on DNA data from more than 600,000 people in 63 studies – might change the tests doctors rely on to establish CHD risk.
The results provide some of the first evidence that the very low-density lipoprotein (VLDL) particles that carry triglycerides are as atherogenic as low-density lipoproteins containing cholesterol.
